Published in Int J Urol on June 01, 2008
Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma. Front Oncol (2015) 0.78
Current approaches to bone-targeted therapy in genitourinary malignancies. Ther Adv Urol (2012) 0.75
A Case of Metastatic Collecting Duct Carcinoma Whose Massive Skull Bone Metastasis was Prominently Reossified by Gemcitabine Plus Cisplatin Chemotherapy Combined with Zoledronic Acid. Urol Case Rep (2017) 0.75
Are bisphosphonates an indispensable tool in the era of targeted therapy for renal cell carcinoma and bone metastases? World J Urol (2013) 0.75
Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy. Eur Urol (2007) 2.15
Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Eur Urol (2007) 2.11
New three-dimensional head-mounted display system, TMDU-S-3D system, for minimally invasive surgery application: procedures for gasless single-port radical nephrectomy. Int J Urol (2012) 2.08
The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet (2004) 1.91
Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin Cancer Res (2003) 1.90
High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy. J Urol (2013) 1.76
Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy. Eur Urol (2008) 1.71
Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study). Diabetes Care (2002) 1.70
Diffusion-weighted magnetic resonance imaging in the differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma. Int J Urol (2011) 1.68
Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma. Eur Urol (2008) 1.67
Prognostic impact of C-reactive protein for determining overall survival of patients with castration-resistant prostate cancer treated with docetaxel. Urology (2011) 1.63
Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clin Cancer Res (2009) 1.61
Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells. Int J Cancer (2011) 1.58
Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology (2009) 1.53
Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate. BJU Int (2008) 1.52
Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL. Urology (2012) 1.48
Muscle-invasive urothelial carcinoma of the bladder. Urology (2007) 1.46
Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy. BJU Int (2015) 1.46
Androgen receptors in gonadotrophs in pituitary cultures from adult male monkeys and rats. Endocrinology (2003) 1.46
Relationship between bone mineral density and androgen-deprivation therapy in Japanese prostate cancer patients. Urology (2010) 1.46
Do testosterone levels have prognostic significance in patients with metastatic prostate cancer treated with combined androgen blockade? Int J Urol (2014) 1.44
Tonotopic specialization of auditory coincidence detection in nucleus laminaris of the chick. J Neurosci (2005) 1.43
Young age as favorable prognostic factor for cancer-specific survival in localized renal cell carcinoma. Urology (2011) 1.43
Renal function after radical nephrectomy: development and validation of predictive models in Japanese patients. Int J Urol (2013) 1.42
Body mass index influences prostate cancer risk at biopsy in Japanese men. Int J Urol (2012) 1.42
Squamous cell carcinoma with sarcomatous feature (so-called carcinosarcoma) of stomach probably metastasized from esophageal tumor: a case report with quick-freezing and deep-etching method. Med Electron Microsc (2004) 1.42
Electron holography on dynamic motion of secondary electrons around sciatic nerve tissues. J Electron Microsc (Tokyo) (2007) 1.40
Successful 2-year-long remission following repeated salvage surgery in a patient with chemotherapy-resistant metastatic nonseminomatous germ cell tumor. Int J Clin Oncol (2007) 1.38
Feasibility of antegrade radical prostatectomy for clinically locally advanced prostate cancer: a comparative study with clinically localized disease. Int J Urol (2010) 1.38
Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method. Cancer (2012) 1.35
Evolution of a neuroprotective function of central nervous system myelin. J Cell Biol (2006) 1.25
Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients. Urology (2008) 1.24
Superior vena cava syndrome caused by supraclavicular lymph node metastasis of renal cell carcinoma. Int J Clin Oncol (2007) 1.18
The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically. BJU Int (2007) 1.14
Differences in the contribution of HLA-DR and -DQ haplotypes to susceptibility to adult- and childhood-onset type 1 diabetes in Japanese patients. Diabetes (2004) 1.08
Gasless single-port access endoscopic surgery in urology: minimum incision endoscopic surgery, MIES. Int J Urol (2009) 1.07
Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. Biochem Biophys Res Commun (2005) 1.07
Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol (2011) 1.07
Portless endoscopic adrenalectomy via a single minimal incision using a retroperitoneal approach: experience with initial 30 cases. Int J Urol (2004) 1.06
Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells. Clin Cancer Res (2006) 1.04
Suppression of VEGF transcription in renal cell carcinoma cells by pyrrole-imidazole hairpin polyamides targeting the hypoxia responsive element. Acta Oncol (2006) 1.04
Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy. Clin Endocrinol (Oxf) (2007) 1.03
Successful therapy of a malignant phyllodes tumor of the prostate after postoperative local failure. Urology (2006) 1.02
Clinical efficacy and prognostic factors for overall survival in Japanese patients with metastatic renal cell cancer treated with sunitinib. BJU Int (2011) 1.00
Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. Int J Clin Oncol (2012) 1.00
Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys (2012) 1.00
Treatment outcome and prognostic factors in renal cell cancer patients with bone metastasis. Clin Exp Metastasis (2011) 0.99
Obstinate cough as a sole presenting symptom of non-metastatic renal cell carcinoma. Int J Urol (2007) 0.98
Inhibition in the balance: binaurally coupled inhibitory feedback in sound localization circuitry. J Neurophysiol (2011) 0.98
Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy. J Urol (2008) 0.98
Denosumab: a new option in the treatment of bone metastases from urological cancers. Onco Targets Ther (2012) 0.98
Head-mounted display for a personal integrated image monitoring system: ureteral stent placement. Urol Int (2014) 0.97
Diverse fusion patterns and heterogeneous clinicopathologic features of renal cell carcinoma with t(6;11) translocation. Am J Surg Pathol (2012) 0.97
Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. J Urol (2007) 0.96
Biomarkers to predict response to sunitinib therapy and prognosis in metastatic renal cell cancer. Cancer Sci (2011) 0.96
A novel technique to prevent postradical retropubic prostatectomy inguinal hernia: the processus vaginalis transection method. Urology (2009) 0.95